134 related articles for article (PubMed ID: 6689431)
1. Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Aug; 11(4):167-71. PubMed ID: 6689431
[TBL] [Abstract][Full Text] [Related]
2. Effects of antithyroid drugs on Con A-induced suppressor cell activity.
Okabe N; Mori R; Miake S; Inoue K
J Clin Lab Immunol; 1984 Apr; 13(4):167-9. PubMed ID: 6234399
[TBL] [Abstract][Full Text] [Related]
3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
4. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
5. Effects of antithyroid drugs on lymphocyte function in vitro.
Hallengren B; Forsgren A; Melander A
J Clin Endocrinol Metab; 1980 Aug; 51(2):298-301. PubMed ID: 7400298
[TBL] [Abstract][Full Text] [Related]
6. Anti-thyroid drugs and lymphocyte function. I. The in vitro effect on blastogenesis and suppressor cell activity.
Goldrath N; Eisenstein Z; Bank H; Shoham J
Clin Exp Immunol; 1982 Oct; 50(1):55-61. PubMed ID: 6217000
[TBL] [Abstract][Full Text] [Related]
7. The in vitro suppression of lectin induced 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil.
Wall JR; Manwar GL; Greenwood DM; Walters BA
J Clin Endocrinol Metab; 1976 Dec; 43(6):1406-9. PubMed ID: 1036744
[TBL] [Abstract][Full Text] [Related]
8. Anti-thyroid drugs and lymphocyte function. II. The in vivo effect on blastogenesis and suppressor cell activity in Graves' disease.
Goldrath N; Shoham J; Bank H; Eisenstein Z
Clin Exp Immunol; 1982 Oct; 50(1):62-9. PubMed ID: 6217001
[TBL] [Abstract][Full Text] [Related]
9. Insulin Autoimmune Syndrome (Hirata's disease): severe hypoglycemic episodes in Graves' hyperthyroidism patient treated with methimazole.
Masjhur JS
Acta Med Indones; 2005; 37(4):214-7. PubMed ID: 16377854
[No Abstract] [Full Text] [Related]
10. Effects of developmental hypothyroidism induced by maternal administration of methimazole or propylthiouracil on the immune system of rats.
Nakamura R; Teshima R; Hachisuka A; Sato Y; Takagi K; Nakamura R; Woo GH; Shibutani M; Sawada J
Int Immunopharmacol; 2007 Dec; 7(13):1630-8. PubMed ID: 17996672
[TBL] [Abstract][Full Text] [Related]
11. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
Chattaway JM; Klepser TB
Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
[TBL] [Abstract][Full Text] [Related]
13. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts.
Heufelder AE; Wenzel BE; Bahn RS
J Clin Endocrinol Metab; 1992 Apr; 74(4):737-42. PubMed ID: 1532179
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes.
Klatka M; Kaszubowska L; Grywalska E; Wasiak M; Szewczyk L; Foerster J; Cyman M; Rolinski J
Folia Histochem Cytobiol; 2014; 52(1):69-77. PubMed ID: 24802963
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of methimazole on dendritic cell (DC) function and DC-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
Autoimmunity; 2007 Jul; 40(5):397-402. PubMed ID: 17612902
[TBL] [Abstract][Full Text] [Related]
16. Studies on the T3 suppression test by the 24-hour thyroidal 131I uptake in patients with Graves' disease: comparison of the effects of propylthiouracil and methylmercaptoimidazole.
Kobayashi I; Maruta S; Mori M; Ishii H; Ishihara H; Iriuchijima T; Takahashi M; Shimomura Y; Fukuda H
Endocrinol Jpn; 1983 Aug; 30(4):491-7. PubMed ID: 6200318
[TBL] [Abstract][Full Text] [Related]
17. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease.
Shi GM; Xu Q; Zhu CY; Yang YL
J Int Med Res; 2009; 37(2):576-82. PubMed ID: 19383254
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes.
Yoshihara A; Luo Y; Ishido Y; Usukura K; Oda K; Sue M; Kawashima A; Hiroi N; Suzuki K
Endocr J; 2019 Apr; 66(4):349-357. PubMed ID: 30814441
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment.
Werner MC; Costa Rosa LF; Romaldini JH; Curi R
Cell Biochem Funct; 1996 Jun; 14(2):97-104. PubMed ID: 8640958
[TBL] [Abstract][Full Text] [Related]
20. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
